BIOINDUSTRY · R&D SERVICES

Heterologous protein expression

A protein that expresses is not the same as a protein you can produce. Expression development is choosing the host, the construct and the conditions that give you an active protein in the quantity your process needs — and that still work when the volume goes up.

Talk to us about your protein
WHERE IT STARTS

Choosing the host is the first decision

Based on the characteristics of the protein and on what you need from it, we develop the vector and the recombinant strain and identify the expression system that suits the application. We run feasibility in more than one host rather than defending a preferred one.

E. coli

The most widely used and the cheapest route to a heterologous protein, and the right first attempt for most targets. Fast, economical feasibility for research quantities first — for activity and selectivity screening — then scale-up and technology transfer when the protein behaves.

Proteins that need disulfide bonds, such as single-domain antibody fragments: strain engineering and periplasmic expression in E. coli, from lab-scale proof of concept to first batches.

Yeast and fungi

Pichia pastoris, Aspergillus and Yarrowia, when the protein needs secretion, glycosylation or a folding environment a bacterium cannot give. We can also build strains that express without expensive, hard-to-scale inducers such as methanol for Pichia.

The protein decides

Size, disulfide bonds, secretion, post-translational modification and toxicity to the host all point to a different answer. Which is why feasibility runs in parallel hosts and the choice is made on data.

How a project runs

Three stages, each ending in a decision rather than a report. How long each takes depends on the protein — we size it after the first conversation, not before.

Stage one

Proof of concept

Vector design and construction, transformation, first expression trials, and the three questions that matter: is the protein there, is it soluble, is it active? Feasibility in one or more hosts, with an honest answer including when the answer is no.

Stage two

Optimisation

Promoter and induction strategy, codon usage, signal peptide and secretion, medium, temperature and induction conditions. Strain improvement where the host is the limit, and a first purification so that active is measured on protein you can actually see.

Stage three

Industrialisation

Fermentation and purification conditions moved toward production, yield per litre, stability of the recombinant strain, and the technology transfer package that lets the process run somewhere other than here.

Batches for your studies

Once the construct works, we produce batches of the recombinant protein or enzyme, purified and characterised, for applications, stability and downstream testing.

What we measure

Expression is easy to claim on a gel. These are the endpoints we report.

  • Expression level — protein per litre and per gram of biomass, with the method declared
  • Soluble fraction — how much is protein you can use and how much is inclusion body
  • Specific activity — units per milligram, because expressed is not the same as active
  • Secretion efficiency — where the host secretes, how much of it actually reaches the medium
  • Strain stability — expression held over generations, and without selective pressure where the process needs that
  • Purification behaviour — how the protein behaves in the first downstream steps, which often decides the host
  • Reproducibility — the same construct and conditions repeated, with the spread declared
  • Scale behaviour — what changes between flask, bench and 100 litres

The laboratory behind it

Equipment

Molecular biologyExtraction, PCR and qPCR, cloning and vector construction, sequence verification and sequencing, up to the whole genome where needed
CultureShake flasks and deep-well for screening, bench bioreactors; CHO cell culture, from screening formats up to the 100-litre scale
StorageCryopreservation and storage at −80 °C, with identity, viability and purity checks on every bank
AnalyticsSDS-PAGE, SEC, Bradford, HPLC and UPLC, activity assays according to the target

What you take away

Strain and constructThe recombinant strain and its vector, characterised and with expression documented
DossierData, conditions tested and results, in the form your technical file needs
Pilot batchProduction at scale when the project reaches that point

Frequently asked questions

What is heterologous expression?

Having an organism produce a protein that is not its own: the sequence is cloned into a vector, the vector is introduced into a host and the host produces the protein.

What is a heterologous host?

The organism that produces the protein: a bacterium, a yeast, a filamentous fungus or a cell line.

How do you choose the host?

According to the protein: whether it needs disulphide bonds or glycosylation, whether it has to be secreted, and the titre and cost the process can bear. When mammalian processing is needed, the route is CHO cell line development.

Start with the protein

Tell us the sequence, what the protein has to do and the quantity you need. We will tell you which host is worth trying first and what feasibility would look like.

Talk to us about your protein

Tell us about your project

Write to us here: the division team will get back to you.